Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M45.1Revenue $M16.0Net Margin (%)-54.0Z-Score-0.5
Enterprise Value $M30.3EPS $-0.4Operating Margin %-56.6F-Score4
P/E(ttm))0Cash Flow Per Share $-0.3Pre-tax Margin (%)-42.1Higher ROA y-yN
Price/Book1.010-y EBITDA Growth Rate %-13.8Quick Ratio3.1Cash flow > EarningsY
Price/Sales1.65-y EBITDA Growth Rate %-1.2Current Ratio4.0Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-27.1Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-34.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M40.3ROI % (ttm)-16.6Gross Margin Increase y-yY

Gurus Latest Trades with KOOL

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
KOOLKen Fisher 2011-09-30 Sold Out -0.0001%$1.2 - $2.13
($1.73)
$ 1.15-34%Sold Out0
KOOLKen Fisher 2011-06-30 Buy $1.91 - $2.47
($2.2)
$ 1.15-48%New holding, 20000 sh.20,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

KOOL is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


KOOL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ENGLE J MELVILLEChairman & CEO 2011-03-10Buy22,500$2.3-51.3 view
ARTILES JORGEVP, Quality/Regulatory Affairs 2010-01-13Buy100$2.44-54.1 view
ENGLE J MELVILLECEO 2009-09-25Buy25,000$2.28-50.88 view
MCENANY PATRICK JDirector 2009-05-19Buy6,250$2.32-51.72 view
ENGLE J MELVILLECEO 2009-05-12Buy25,000$2.2-49.09 view
MCENANY PATRICK JDirector 2009-05-08Buy6,250$2.12-47.17 view
HUCKEL HUBERT E MDDirector 2007-11-16Buy36,500$7.8-85.64 view
SEGAL DANIELVP Sales & Marketing 2007-03-01Buy750$12.56-91.08 view
HUCKEL HUBERT E MDDirector 2006-05-12Buy12,500$16.08-93.03 view
BARRY GEORGE JDirector 2006-05-12Buy250$16.28-93.12 view

Press Releases about KOOL :

    Quarterly/Annual Reports about KOOL:

    News about KOOL:

    Articles On GuruFocus.com
    comment on KOOL Dec 01 2011 
    comment on KOOL Aug 26 2011 
    THERMOGENESIS Corp. Reports Operating Results (10-Q) Feb 11 2011 
    THERMOGENESIS Corp. Reports Operating Results (10-Q) Nov 04 2010 
    THERMOGENESIS Corp. Reports Operating Results (10-Q) May 07 2010 
    THERMOGENESIS Corp. Reports Operating Results (10-Q) Feb 04 2010 
    THERMOGENESIS Corp. Reports Operating Results (10-Q) Nov 09 2009 
    THERMOGENESIS Corp. (KOOL) CEO J Melville Engle buys 100,000 Shares Sep 28 2009 
    THERMOGENESIS Corp. (KOOL) CEO J Melville Engle buys 100,000 Shares May 12 2009 
    THERMOGENESIS Corp. Reports Operating Results (10-Q) May 07 2009 

    More From Other Websites
    Cesca Therapeutics Announces Agreement With New York Upstate Cord Blood Bank Oct 13 2014
    Cesca Therapeutics to Present at Stem Cell Meeting on the Mesa Oct 06 2014
    CESCA THERAPEUTICS INC. Financials Oct 04 2014
    10-K for Cesca Therapeutics, Inc. Oct 01 2014
    CESCA THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Sep 29 2014
    Cesca Therapeutics Announces Approval of Its AXP(R) AutoXpress(R) System in Taiwan Sep 29 2014
    Cesca Therapeutics Reports Fourth Quarter and Full Fiscal 2014 Results Sep 29 2014
    Cesca Therapeutics Reschedules Fourth Quarter and Full Year Earnings Release Sep 25 2014
    Q4 2014 Cesca Therapeutics Inc Earnings Release - After Market Close Sep 25 2014
    Cesca Therapeutics to Announce Fourth Quarter and Fiscal 2014 Year End Results on September 25, 2014 Sep 23 2014
    Cesca Therapeutics to Present at Aegis Healthcare & Technology Conference Sep 10 2014
    CESCA THERAPEUTICS INC. Files SEC form 8-K, Other Events Sep 10 2014
    Cesca Therapeutics to Present at the Rodman & Renshaw(R) 16th Annual Global Investment Conference Sep 04 2014
    Cesca Therapeutics Advocates Benefits of Cell Therapy to the Centers for Medicare and Medicaid... Aug 27 2014
    CESCA THERAPEUTICS INC. Files SEC form 8-K, Change in Directors or Principal Officers Aug 22 2014
    Cesca Therapeutics and Fortis Healthcare Announce Master Collaboration Agreement Aug 05 2014
    CESCA THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jun 16 2014
    CESCA THERAPEUTICS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Jun 13 2014
    Cesca Therapeutics files $50M mixed securities shelf May 21 2014
    Cesca Therapeutics' (KOOL) CEO Matthew Plavan on Q3 2014 Results - Earnings Call Transcript May 15 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK